Results 61 to 70 of about 26,281 (176)

Lung V5 and Planning Target Volume/Lung Volume Ratio as Independent Risk Factors for ≥Grade 2 Radiation Pneumonitis after Moderately Hypofractionated Radiotherapy: A Retrospective Study

Asia-Pacific Journal of Clinical Oncology, EarlyView.
Lung V5 and the planning target volume/lung volume ratio were identified as independent dosimetric risk factors for clinically significant radiation pneumonitis following moderately hypofractionated radiotherapy for lung cancer. Maintaining V5 < 35% may help mitigate this risk in clinical practice.
YuanYou Yang, FengXia Luo, Chao Wang, Gang Ren   +3 more
wiley   +1 more source

Ablative radiotherapy in castration‐resistant prostate cancer

BJU International, EarlyView.
Objective To prove the oncological benefit of ablative radiotherapy in patients with up to five metastases from castration‐resistant prostate cancer (CRPC) a single‐centre randomised trial was initiated. Patients and Methods This monocentric, randomised, phase II clinical trial enrolled patients with up to five prostate‐specific membrane antigen ...
Tobias Hölscher, Fabian Lohaus, Lydia Koi, Jörg Kotzerke, Sebastian Hoberück, Christian Thomas, Angelika Borkowetz, Steffen Löck, Mechthild Krause, Esther G.C. Troost   +9 more
wiley   +1 more source

Novel Radiotherapy Delivery Modalities and Their Potential to Synergize with Immunotherapy

Biomedicines
The marriage of radiotherapy (RT) and immune checkpoint inhibition (ICI) has been driven, to date, largely by conventional and stereotactic body delivery [...]
Ivaylo B. Mihaylov, Benjamin Spieler
doaj   +1 more source

Mapping the Radiopharmaceutical Therapy Landscape for Prostate Cancer: Insights Into Global Clinical Trial Trends and Future Directions

Med Research, EarlyView.
Zhiwu Dong, Sixiang Yan, Xiaodong Liu, Peng Gu   +3 more
wiley   +1 more source

Transporter‐Associated Therapeutic Efficacy of an SMVT‐Targeted Boron Carrier in Boron Neutron Capture Therapy

Cancer Science, EarlyView.
The transporter‐associated BNCT strategy using BBCIP with or without BPA according to tumor transporter characteristics. BPA showed greater efficacy in LAT1‐dominant F98 glioma, whereas BBCIP was more effective in SMVT‐high CRL1666 tumors, suggesting the potential utility of transporter‐based boron carrier selection in BNCT.
Kenichiro Eza, Kohei Tsujino, Rina Shidoh‐Kazuki, Yoshiki Fujikawa, Hideki Kashiwagi, Gen Futamura, Ryo Hiramatsu, Toshihiro Takami, Masahiko Wanibuchi, Naonori Hu, Hiroki Tanaka, Minoru Suzuki, Kai Nishimura, Shota Tanaka, Hiroyuki Nakamura, Shinji Kawabata   +15 more
wiley   +1 more source

Stereotactic radiotherapy for patients with bone metastases: a selected group with low rate of radiation treatment during the last month of life?

Radiation Oncology
Background Complex high-precision radiotherapy, such as stereotactic body radiotherapy (SBRT), should only be offered to patients with sufficiently long survival.
Carsten Nieder, Ellinor C. Haukland, Luka Stanisavljevic, Bård Mannsåker   +3 more
doaj   +1 more source

Biopsy of Iris and Anterior Chamber Tumours: Fine Needle, Minimally Invasive and Excision Techniques ‐ Review

Clinical &Experimental Ophthalmology, EarlyView.
ABSTRACT Several benign, inflammatory and malignant lesions can present as iris or anterior chamber masses, including iris naevi, cysts, adenomas, leiomyomas, nodules, vascular tumours, melanomas, metastases, as well as iris and pigment epithelium adenocarcinomas. Fortunately, benign iris lesions are much more common than malignant tumours and many can
Charles N. J. McGhee, Joevy Z. Lim, Peter W. Hadden, Jie Zhang   +3 more
wiley   +1 more source

Closing the gap – lung cancer evaluation and treatment among indigenous and non‐indigenous patients in the Top End, Northern Territory, Australia

Internal Medicine Journal, EarlyView.
ABSTRACT Background Lung cancer outcomes have been reported to be poorer in the indigenous population of the Northern Territory (NT). We examine whether longer diagnostic and treatment time frames contribute to the observed survival disparity. Aims Assess the time frames to diagnosis and treatment of lung cancer in the Top End, NT, Australia.
Angus Lloyd, Paul DeKlerk, Subash Heraganahally, Lin Mo   +3 more
wiley   +1 more source

Are respiratory physicians adherent to guidelines when evaluating pulmonary nodules?

Internal Medicine Journal, EarlyView.
Abstract Introduction Although fewer than 1% of pulmonary nodules are malignant, appropriate evaluation is essential in optimising patient outcomes. The 2017 Fleischner Society Guidelines provide recommendations on management of incidentally detected nodules; however, studies to date have shown variable guideline adherence.
Laura Tu, Raymond Wong, Amy Baker, Fergal O’Donoghue, Christine F McDonald, Tracy L. Leong   +5 more
wiley   +1 more source

Stereotactic body radiotherapy in lung cancer: an update

Jornal Brasileiro de Pneumologia, 2015
For early-stage lung cancer, the treatment of choice is surgery. In patients who are not surgical candidates or are unwilling to undergo surgery, radiotherapy is the principal treatment option.
Carlos Eduardo Cintra Vita Abreu, Paula Pratti Rodrigues Ferreira, Fabio Ynoe de Moraes, Wellington Furtado Pimenta Neves Jr, Rafael Gadia, Heloisa de Andrade Carvalho   +5 more
doaj   +1 more source